A touch of cooling may help by Zaaqoq, AM & Yende, S
Expanded abstract
Citation
Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat 
A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, 
Brun-Buisson C, Lemaire F, Brochard L: Multicenter 
randomized controlled clinical trial of fever control 
by external cooling to diminish vasopressor require-
ments in septic shock. Assistance Publique-Hôpitaux 
de Paris, France. Am J Respir Crit Care Med 2012, 
185:1088-1095.
Background
Fever control may improve vascular tone and decrease 
oxygen consumption; however, fever may help combat 
infection.
Methods
Objective: To determine whether fever control by external 
cooling diminishes vasopressor requirements in septic 
shock.
Design: A multicenter randomized controlled trial.
Setting: Seven ICUs in France.
Subjects: Febrile patients with septic shock requiring 
vasopressors, mechanical ventilation, and sedation.
Intervention: Patients were randomly allocated to exter nal 
cooling to achieve normothermia (36.5 to 37.8°C) for 
48 hours.
Outcomes: Th e primary outcome was the number of 
patients with a 50% decrease in baseline vasopressor dose 
after 48 hours. Secondary outcomes were the numbers of 
patients with a 50% baseline vasopressor dose decrease 
after 2, 12, 24, and 36 hours, the percentage of patients 
requiring a vasopressor dose increase within 48 hours of 
baseline, the percentage of patients with shock reversal in 
the ICU, the change in Sequential Organ Failure Assess-
ment score (ΔSOFA) versus baseline, and all-cause 
mortality on day 14 and at ICU and hospital discharge.
Results
Th ere were 200 patients randomized, 101 to the cooling 
group and 99 to the no-cooling group. Th e percentage of 
patients with a 50% vasopressor dose decrease versus 
baseline was not signiﬁ cantly diﬀ erent at 48  hours of 
treatment (72% vs. 61%; absolute diﬀ erence, 11%; 95% 
conﬁ dence interval (CI), –23 to 2; P  = 0.4), although it 
was at 12  hours (54% vs. 20%; absolute diﬀ erence, 34%; 
95% CI, –46 to –21; P  <0.001). External cooling signi-
ﬁ cantly reduced the number of patients needing a vaso-
pressor dose increase (34% vs. 52%; absolute diﬀ erence, 
–18%; 95% CI, –4 to –31%; P  =  0.011) and signiﬁ cantly 
increased the shock reversal during the study period 
(86% vs. 73%; absolute diﬀ erence, 13%; 95% CI, 2 to 25%; 
P = 0.021). Day 14 mortality was signiﬁ cantly lower in the 
cooling group (19% vs. 34%; absolute diﬀ erence, –16%; 
95% CI, –28 to –4; P  =  0.013), but mortality was not 
diﬀ erent at ICU and hospital discharge.
Conclusions
Fever control using external cooling was safe, and 
decreased vasopressor requirements and early mortality 
in septic shock.
Commentary
Septic shock, deﬁ ned as sepsis and hypotension refrac-
tory to ﬂ uid resuscitation, is the leading cause of death in 
noncoronary ICUs, and is associated with mortality of 40 
to 60% [1-3]. Initiated by an infection, severe sepsis and 
septic shock may be due to a dysregulated inﬂ ammatory 
response [4].
Fever is deﬁ ned as core temperature ≥38.3°C [5,6]. 
Approxi mately 90% of patients with severe sepsis are 
febrile [7]. During sepsis, fever occurs in response to 
endogenous (IL-1β, TNFα, IFNγ, prostaglandin E2) and/
or exogenous pyrogenic substances that reset the 
thermo regulatory center. Fever is an important adaptive 
response to infection [8]. Although it has beneﬁ cial and 
detrimental eﬀ ects, the net role of fever in the patho-
physiology of septic shock is unclear.
Beneﬁ cial eﬀ ects include decreased bacterial and viral 
growth due to denaturation of essential enzymes, such as 
viral polymerase and/or promoter complexes [9,10]. 
Fever also alters the immune response. Heat shock © 2010 BioMed Central Ltd
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proteins induced by fever have direct cytoprotective 
eﬀ ects and downregulate NF-κB, subsequently modifying 
the expression of inﬂ ammatory mediators and limiting 
the collateral damage of inﬂ ammation. Fever also 
enhances cytotoxic activity of eﬀ ector cells, such as 
neutrophils and macrophages, leading to more rapid 
pathogen clearance [11]. Detrimental eﬀ ects of fever 
include increased oxygen consumption. In patients with 
septic shock there is limited ability to meet the increased 
metabolic demands because of disturbances in cardiac 
and pulmonary function [12]. In febrile critically ill 
patients, the reduction of fever from 39 to 37°C led to a 
decrease in oxygen consumption and unloaded the 
cardio pulmonary system, which favored resuscitation of 
patients with limited oxygen delivery [13].
Pharmacologic approaches have been tested to control 
fever in patients with infection. For instance, ibuprofen 
has been studied in a randomized controlled trial in 
humans and no improvement of survival was found, even 
though the drug did have a salutary eﬀ ect on core 
temperature and metabolic rate [14]. External cooling is 
another option to control fever without exposing the 
patient to the potential adverse eﬀ ects of antipyretic 
drugs, such as increased risk of bleeding and hepatic and 
renal toxicity [12].
Th e current study is a multicenter randomized con-
trolled trial, set to determine the eﬀ ect of external cooling 
on vascular tone. Th e primary endpoint was 50% reduc-
tion in baseline vasopressor dose at 48 hours, while the 
secondary endpoints were 50% reduction in baseline 
vaso pressor at various time points over 48  hours, vaso-
pressor dose increase, shock reversal, change in Sequential 
Organ Failure Assessment score, and mortality on day 14 
and at ICU and hospital discharge.
Th e hemodynamic improvement was evident through 
shock reversal, smaller change in Sequential Organ 
Failure Assessment score, and fewer cases of renal replace-
ment therapy initiation in the cooling arm. Additionally, 
external cooling reduced day  14 mortality but did not 
change ICU or hospital mortality. Th e beneﬁ cial eﬀ ect of 
cooling was more pronounced in the subgroup receiving 
the highest vasopressor dose.
Th e study has multiple strengths. Patients were en-
rolled on average within 1 hour from ICU admission and 
cooling was initiated promptly. Vasopressor manage ment 
was protocolized. Th e study reported a good safety 
proﬁ le for external cooling, considering the patients were 
sedated and on mechanical ventilation and considering 
neuromuscular blockade was used in a large proportion 
of the study population. Th e study has some limitations. 
First, there was no mechanistic explanation (for example, 
reduced oxygen consumption, improved vascular tone, or 
diﬀ erences in inﬂ ammatory response) for the beneﬁ cial 
eﬀ ect of fever control. Second, the eﬀ ect of fever 
reduction on hemo dynamic stability was temporary, 
since there was no diﬀ erence in the number of patients 
with 50% reduction in vasopressor use at 48 hours. Also, 
no diﬀ erence in mortality at ICU or hospital discharge 
was observed. Although most patients were on adequate 
antimicrobial coverage by the time of cooling, there was a 
trend toward an increased incidence of nosocomial 
infections on day 14 in the cooling group.
Recommendation
Th e results of this study suggest no harm in external 
cooling to control fever in patients with septic shock. A 
large multicenter randomized control trial is required to 
determine the eﬃ  cacy and to shed insights on the 
underlying mechanistic eﬀ ect of this intervention before 
it can be used routinely for septic shock patients.
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